A research team from the University of Copenhagen published a study in Nature Metabolism, developing an insulin resistance prediction model using 13 circulating proteins and three routine clinical indicators. In approximately 20,000 UK Biobank participants, the model predicted type 2 diabetes with performance comparable to HbA1c and was associated with fatty liver disease, cardiovascular disease, and chronic kidney disease. Further support came from an independent cohort of approximately 1,700 participants followed for nearly 20 years.
Source:Inside Precision Medicine · Read the original article
Leave a Reply